Bank Of New York Mellon Corp Greenwich Life Sciences, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.14 - $20.36 $72,213 - $205,921	-10,114 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$21.76 - $39.43 $3,938 - $7,136	181 Added 1.82%	10,114 $246,000
Q3 2021 Nov 12, 2021	BUY	$38.65 - $46.11 $126,346 - $150,733	3,269 Added 49.05%	9,933 $388,000
Q2 2021 Aug 11, 2021	BUY	$31.24 - $53.6 $208,183 - $357,190	6,664 New	6,664 $299,000

1.01M

Ticker GLSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,848,200
Market Cap $173M
Description
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.